Quoin Pharmaceuticals (QNRX) Research & Development (2021 - 2026)

Quoin Pharmaceuticals has disclosed Research & Development across 6 years of filings, most recently posting $3.6 million for Q2 2026.

• In Q2 2026, Research & Development rose 76.88% year-over-year to $3.6 million; the TTM figure through Jun 2026 stood at $12.4 million (up 89.78% YoY), while the FY2025 annual figure was $9.8 million, up 172.1% from the prior year.
• Research & Development came in at $3.6 million for Q2 2026 at Quoin Pharmaceuticals, up from $3.4 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $3.6 million in Q2 2026 to a low of $587503.0 in Q2 2024.
• Average Research & Development over 5 years is $1.5 million, with a median of $967754.5 recorded in 2024.
• Year-over-year, Research & Development dropped 18.91% in 2024 and surged 249.03% in 2025.
• Over 5 years, Research & Development stood at $830000.0 in 2022, then climbed by 0.29% to $832391.0 in 2023, then climbed by 26.17% to $1.1 million in 2024, then surged by 194.88% to $3.1 million in 2025, then increased by 17.12% to $3.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $3.6 million in Q2 2026, $3.4 million in Q1 2026, and $3.1 million in Q4 2025.